Applied DNA Sciences (APDN) Misses Q2 EPS by 1535c

Applied DNA Sciences (NASDAQ: APDN) reported Q2 EPS of ($15.35). Revenue for the quarter came in at $980 thousand.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.

You May Also Be Interested In

• Citigroup set to join top banks in Anthropic IPO - Bloomberg
• Jefferies Downgrades Pop Mart International Group Ltd (9992:HK) to Hold
• Bicara Therapeutics (BCAX) Reiterated at Market Outperform by Citizens as Pivotal Trial Advances